Catalent to purchase Bristol-Myers Squibb manufacturing facility in Anagni, Italy
Bristol-Myers Squibb and Catalent announced that Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy. The companies anticipate completing the transaction by the end of 2019. June 19, 2019